This will more than likely have a very negative impact on Movantik's sales. The guidelines say that opioids should be reserved for cancer pain and end-of-life pain management only. Should be interesting going forward for Movantik.
http://www.forbes.com/sites/robertg...lines-to-combat-opioid-epidemic/#78b9a7569fa3
http://www.forbes.com/sites/robertg...lines-to-combat-opioid-epidemic/#78b9a7569fa3